Publications by authors named "Stuart Gallagher"

Claim this Profile
B
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment.
Hsin-Yi Tseng, Sara Alavi, Stuart Gallagher, Helen M McGuire, Peter Hersey

Pigment Cell Melanoma Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma.
Farzana Ahmed, Hsin-Yi Tseng, Antonio Ahn, Dilini Gunatilake, Sara Alavi, Stuart J Gallagher

J Invest Dermatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis.
Stuart J Gallagher, Teresa Bailey, Robert V Rawson, Annabelle M Mahar, John F Thompson

Pathology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.
Abdullah Al Emran, Hsin-Yi Tseng, Dilini Gunatilake, Stuart J Cook, Farzana Ahmed, Stuart J Gallagher

J Invest Dermatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex bias of females in survival from cancer and infections. Is X the answer?
Abdullah Al Emran, Stuart J Gallagher, Jessamy C Tiffen, Peter Hersey

Br J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma.
Jessamy Tiffen, Stuart J Gallagher, Fabian Filipp, Dilini Gunatilake, Abdullah Al Emran

J Invest Dermatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.
Hsin-Yi Tseng, Jan Dreyer, Abdullah Al Emran, Dilini Gunatilake, Mehdi Pirozyan, Stuart Gallagher

Int J Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
Abdullah Al Emran, Hsin-Yi Tseng, Mikaela C Coleman, Jessamy Tiffen, Stuart Cook, Stuart Gallagher

Pigment Cell Melanoma Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Abdullah Al Emran, Jérémie Nsengimana, Gaya Punnia-Moorthy, Ulf Schmitz, Stuart J Gallagher

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.
Florencia Paula Madorsky Rowdo, Antonela Barón, Stuart John Gallagher, Peter Hersey, Abdullah Al Emran

Int J Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding light on dabrafenib-induced fevers in patients with melanoma.
Peter Hersey, Jessamy C Tiffen, Stuart J Gallagher

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C57BL/6 congenic mouse NRAS melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.
Valérie Petit, Jeremy Raymond, Christophe Alberti, Marie Pouteaux, Stuart J Gallagher

Pigment Cell Melanoma Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.
Abdullah Al Emran, Aniruddha Chatterjee, Euan J Rodger, Jessamy C Tiffen, Stuart J Gallagher

Trends Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIRT6 haploinsufficiency induces BRAF melanoma cell resistance to MAPK inhibitors via IGF signalling.
Thomas Strub, Flavia G Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska, Stuart J Gallagher

Nat Commun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation of melanoblast displacements reveals new features of developmental migration.
Pascal Laurent-Gengoux, Valérie Petit, Zackie Aktary, Stuart Gallagher, Luke Tweedy

Development· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.
Aniruddha Chatterjee, Euan J Rodger, Antonio Ahn, Peter A Stockwell, Matthew Parry, Stuart J Gallagher

iScience· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.
Stuart J Gallagher, Dilini Gunatilake, Kimberley A Beaumont, Danae M Sharp, Jessamy C Tiffen

Int J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.
Helen M McGuire, Elena Shklovskaya, Jarem Edwards, Paul R Trevillian, Geoffrey W McCaughan, Stuart J Gallagher

Cancer Immunol Immunother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic modulation in cancer immunotherapy.
Stuart J Gallagher, Elena Shklovskaya, Peter Hersey

Curr Opin Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 as a mediator of treatment resistance in melanoma.
Jessamy C Tiffen, Stuart J Gallagher, Hsin-Yi Tseng, Fabian V Filipp, Barbara Fazekas de St. Groth

Pigment Cell Melanoma Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
Kavitha Gowrishankar, Dilini Gunatilake, Stuart J Gallagher, Jessamy Tiffen, Helen Rizos

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.
Jessamy Tiffen, Stephen Wilson, Stuart J Gallagher, Peter Hersey, Fabian V Filipp

Neoplasia· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.
Jessamy C Tiffen, Dilini Gunatilake, Stuart J Gallagher, Kavitha Gowrishankar, Anja Heinemann

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.
Stuart J Gallagher, Jessamy C Tiffen, Peter Hersey

Cancers (Basel)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling.
Anja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, James S Wilmott, Dilini Gunatilake, Stuart J Gallagher

Oncotarget· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis